Home › Non-Small Cell Lung Cancer › Ohio › Parma
Non-Small Cell Lung Cancer clinical trials in Parma, OH
3 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Parma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecruitingPhase 3
- University Hospitals Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Cleveland Clinic Cancer Center Independence, Independence · 5 mi away
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- University Hospitals Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX143 studies
- New York City, NY123 studies
- Arlington, VA111 studies
- Nashville, TN97 studies
- Los Angeles, CA92 studies
- Boston, MA87 studies
- St. Louis, MO68 studies
- Baltimore, MD60 studies
- San Antonio, TX60 studies
- Chicago, IL59 studies
- Columbus, OH57 studies
- Seattle, WA55 studies
Other studies in Parma
- Ulcerative Colitis9 studies
- Steatotic Liver Disease8 studies
- Crohn's Disease6 studies
- Schizophrenia5 studies
- Lung Cancer5 studies
- Ovarian Cancer4 studies
- Alzheimer's Disease4 studies
- Psychotic Disorders4 studies
- Endometrial Cancer4 studies
- Major Depressive Disorder4 studies
- Cancer (all types)3 studies
- Lupus3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.